Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis

2.

Sarrazin

S

,

Lamanna

WC

,

Esko

JD

.

Heparan sulfate proteoglycans

.

Cold Spring Harb Perspect Biol

.

2011

;

3

(

7

):

a004952

.

3.

Bülow

HE

,

Hobert

O

.

The molecular diversity of glycosaminoglycans shapes animal development

.

Annu Rev Cell Dev Biol

.

2006

;

22

:

375

-

407

.

4.

Xu

D

,

Esko

JD

.

Demystifying heparan sulfate–protein interactions

.

Annu Rev Biochem

.

2014

;

83

:

129

-

157

.

5.

Iozzo

RV

,

Schaefer

L

.

Proteoglycan form and function: a comprehensive nomenclature of proteoglycans

.

Matrix Biol

.

2015

;

42

:

11

-

55

.

6.

Papy-Garcia

D

,

Albanese

P

.

Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells

.

Glycoconj J

.

2017

;

34

(

3

):

377

-

391

.

7.

Roberts

R

,

Gallagher

J

,

Spooncer

E

,

Allen

TD

,

Bloomfield

F

,

Dexter

TM

.

Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

.

Nature

.

1988

;

332

(

6162

):

376

-

378

.

8.

Rodgers

KD

,

San Antonio

JD

,

Jacenko

O

.

Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators

.

Dev Dyn

.

2008

;

237

(

10

):

2622

-

2642

.

9.

Ramsden

L

,

Rider

CC

.

Selective and differential binding of interleukin (IL)-1α, IL-1β, IL-2 and IL-6 to glycosaminoglycans

.

Eur J Immunol

.

1992

;

22

(

11

):

3027

-

3031

.

10.

Gupta

P

,

Oegema

TR

,

Brazil

JJ

,

Dudek

AZ

,

Slungaard

A

,

Verfaillie

CM

.

Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche

.

Blood

.

1998

;

92

(

12

):

4641

-

4651

.

11.

Lortat-Jacob

H

,

Garrone

P

,

Banchereau

J

,

Grimaud

J-A

.

Human interleukin 4 is a glycosaminoglycan-binding protein

.

Cytokine

.

1997

;

9

(

2

):

101

-

105

.

12.

den Dekker

E

,

Grefte

S

,

Huijs

T

, et al.

Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells

.

J Immunol

.

2008

;

180

(

6

):

3680

-

3688

.

13.

Lipscombe

R J

,

Nakhoul

AM

,

Sanderson

CJ

,

Coombe

DR

.

Interleukin-5 binds to heparin/heparan sulfate. a model for an interaction with extracellular matrix

.

J Leukoc Biol

.

1998

;

63

(

3

):

342

-

350

.

14.

Mummery

RS

,

Rider

CC

.

Characterization of the heparin-binding properties of IL-6

.

J Immunol

.

2000

;

165

(

10

):

5671

-

5679

.

15.

Clarke

D

,

Katoh

O

,

Gibbs

R

,

Griffiths

S

,

Gordon

M

.

Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance

.

Cytokine

.

1995

;

7

(

4

):

325

-

330

.

16.

Webb

L

,

Ehrengruber

MU

,

Clark-Lewis

I

,

Baggiolini

M

,

Rot

A

.

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8

.

Proc Natl Acad Sci U S A

.

1993

;

90

(

15

):

7158

-

7162

.

17.

Pichert

A

,

Samsonov

SA

,

Theisgen

S

, et al.

Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling

.

Glycobiology

.

2012

;

22

(

1

):

134

-

145

.

18.

Zong

C

,

Venot

A

,

Li

X

, et al.

Heparan sulfate microarray reveals that heparan sulfate–protein binding exhibits different ligand requirements

.

J Am Chem Soc

.

2017

;

139

(

28

):

9534

-

9543

.

19.

Salek-Ardakani

S

,

Arrand

JR

,

Shaw

D

,

Mackett

M

.

Heparin and heparan sulfate bind interleukin-10 and modulate its activity

.

Blood

.

2000

;

96

(

5

):

1879

-

1888

.

20.

Künze

G

,

Gehrcke

J-P

,

Pisabarro

MT

,

Huster

D

.

NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10

.

Glycobiology

.

2014

;

24

(

11

):

1036

-

1049

.

21.

Hasan

M

,

Najjam

S

,

Gordon

MY

,

Gibbs

RV

,

Rider

CC

.

IL-12 is a heparin-binding cytokine

.

J Immunol

.

1999

;

162

(

2

):

1064

-

1070

.

22.

Reeves

EP

,

Williamson

M

,

Byrne

B

, et al.

IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis

.

J Immunol

.

2010

;

184

(

3

):

1642

-

1652

.

23.

Chen

Z

,

Cui

Y

,

Yao

Y

, et al.

Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation

.

Sci Immunol

.

2023

;

8

(

80

):

eadd1728

.

24.

Lau

EK

,

Paavola

CD

,

Johnson

Z

, et al.

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo

.

J Biol Chem

.

2004

;

279

(

21

):

22294

-

22305

.

25.

Sweeney

MD

,

Yu

Y

,

Leary

JA

.

Effects of sulfate position on heparin octa saccharide binding to CCL2 examined by tandem mass spectrometry

.

J Am Soc Mass Spectrom

.

2006

;

17

(

8

):

1114

-

1119

.

26.

Schenauer

MR

,

Yu

Y

,

Sweeney

MD

,

Leary

JA

.

CCR2 chemokines bind selectively to acetylated heparan sulfate octa saccharides

.

J Biol Chem

.

2007

;

282

(

35

):

25182

-

25188

.

27.

Gray

AL

,

Karlsson

R

,

Roberts

ARE

, et al.

Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors

.

Cell Rep

.

2023

;

42

(

1

):

111930

.

28.

Koopmann

W

,

Ediriwickrema

C

,

Krangel

MS

.

Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1β

.

J Immunol

.

1999

;

163

(

4

):

2120

-

2127

.

29.

Mbemba

E

,

Slimani

H

,

Atemezem

A

,

Saffar

L

,

Gattegno

L

.

Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells

.

Biochim Biophys Acta

.

2001

;

1510

(

1-2

):

354

-

366

.

30.

Ali

S

,

Robertson

H

,

Wain

JH

,

Isaacs

JD

,

Malik

G

,

Kirby

JA

.

A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation

.

J Immunol

.

2005

;

175

(

2

):

1257

-

1266

.

31.

Cochran

S

,

Li

CP

,

Ferro

V

.

A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

.

Glycoconj J

.

2009

;

26

(

5

):

577

-

587

.

32.

Ellyard

JI

,

Simson

L

,

Bezos

A

,

Johnston

K

,

Freeman

C

,

Parish

CR

.

Eotaxin selectively binds heparin: an interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo

.

J Biol Chem

.

2007

;

282

(

20

):

15238

-

15247

.

33.

Culley

FJ

,

Fadlon

EJ

,

Kirchem

A

,

Williams

TJ

,

Jose

PJ

,

Pease

JE

.

Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines

.

Eur J Immunol

.

2003

;

33

(

5

):

1302

-

1310

.

34.

Pum

A

,

Ennemoser

M

,

Gerlza

T

,

Kungl

AJ

.

The role of heparan sulfate in CCL26-induced eosinophil chemotaxis

.

Int J Mol Sci

.

2022

;

23

(

12

):

6519

.

35.

Kishimoto

S

,

Nakamura

S

,

Hattori

H

, et al.

Human stem cell factor (SCF) is a heparin-binding cytokine

.

J Biochem

.

2009

;

145

(

3

):

275

-

278

.

36.

Gordon

MY

,

Riley

GP

,

Watt

SM

,

Greaves

MF

.

Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment

.

Nature

.

1987

;

326

(

6111

):

403

-

405

.

37.

Lyon

M

,

Deakin

JA

,

Mizuno

K

,

Nakamura

T

,

Gallagher

JT

.

Interaction of hepatocyte growth factor with heparan sulfate. elucidation of the major heparan sulfate structural determinants

.

J Biol Chem

.

1994

;

269

(

15

):

11216

-

11223

.

38.

Karlsson

R

,

Chopra

P

,

Joshi

A

, et al.

Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates

.

Sci Adv

.

2021

;

7

(

52

):

eabl6026

.

39.

Murphy

JW

,

Cho

Y

,

Sachpatzidis

A

,

Fan

C

,

Hodsdon

ME

,

Lolis

E

.

Structural and functional basis of CXCL12 (stromal cell-derived factor-1α) binding to heparin

.

J Biol Chem

.

2007

;

282

(

13

):

10018

-

10027

.

40.

Monneau

YR

,

Luo

L

,

Sankaranarayanan

NV

, et al.

Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signaling rely on distinct domains

.

Open Biol

.

2017

;

7

(

10

):

170133

.

41.

Kreuger

J

,

Prydz

K

,

Pettersson

RF

,

Lindahl

U

,

Salmivirta

M

.

Characterization of fibroblast growth factor 1 binding heparan sulfate domain

.

Glycobiology

.

1999

;

9

(

7

):

723

-

729

.

42.

Yayon

A

,

Klagsbrun

M

,

Esko

JD

,

Leder

P

,

Ornitz

DM

.

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

.

Cell

.

1991

;

64

(

4

):

841

-

848

.

43.

Gitay-Goren

H

,

Soker

S

,

Vlodavsky

I

,

Neufeld

G

.

The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules

.

J Biol Chem

.

1992

;

267

(

9

):

6093

-

6098

.

44.

Robinson

CJ

,

Mulloy

B

,

Gallagher

JT

,

Stringer

SE

.

VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase

.

J Biol Chem

.

2006

;

281

(

3

):

1731

-

1740

.

45.

Higashiyama

S

,

Abraham

JA

,

Miller

J

,

Fiddes

JC

,

Klagsbrun

M

.

A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF

.

Science

.

1991

;

251

(

4996

):

936

-

939

.

46.

Feyzi

E

,

Lustig

F

,

Fager

G

,

Spillmann

D

,

Lindahl

U

,

Salmivirta

M

.

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

.

J Biol Chem

.

1997

;

272

(

9

):

5518

-

5524

.

47.

Reijmers

RM

,

Groen

RWJ

,

Kuil

A

, et al.

Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival

.

Blood

.

2011

;

117

(

23

):

6162

-

6171

.

48.

Hendriks

J

,

Planelles

L

,

de Jong-Odding

J

, et al.

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation

.

Cell Death Differ

.

2005

;

12

(

6

):

637

-

648

.

49.

Luster

AD

,

Greenberg

SM

,

Leder

P

.

The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

.

J Exp Med

.

1995

;

182

(

1

):

219

-

231

.

50.

Lortat-Jacob

H

,

Grimaud

J-A

.

Interferon-γ binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule

.

FEBS Lett

.

1991

;

280

(

1

):

152

-

154

.

51.

Lortat-Jacob

H

,

Grimaud

J-A

.

Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains ad involves carboxylic-but not N-sulfated-groups

.

Biochim Biophys Acta

.

1992

;

1117

(

2

):

126

-

130

.

52.

Lyon

M

,

Rushton

G

,

Gallagher

JT

.

The interaction of the transforming growth factor-βs with heparin/heparan sulfate is isoform-specific

.

J Biol Chem

.

1997

;

272

(

29

):

18000

-

18006

.

53.

McCaffrey

TA

,

Falcone

DJ

,

Du

B

.

Transforming growth factor-β1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1

.

J Cell Physiol

.

1992

;

152

(

2

):

430

-

440

.

54.

Hu

Z

,

Wang

C

,

Xiao

Y

, et al.

NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development

.

J Cell Sci

.

2009

;

122

(

Pt 8

):

1145

-

1154

.

55.

Denardo

A

,

Elli

S

,

Federici

S

, et al.

BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues

.

Biochim Biophys Acta Gen Subj

.

2021

;

1865

(

2

):

129799

.

56.

Irie

A

,

Habuchi

H

,

Kimata

K

,

Sanai

Y

.

Heparan sulfate is required for bone morphogenetic protein-7 signaling

.

Biochem Biophys Res Commun

.

2003

;

308

(

4

):

858

-

865

.

57.

Paine-Saunders

S

,

Viviano

BL

,

Economides

AN

,

Saunders

S

.

Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients

.

J Biol Chem

.

2002

;

277

(

3

):

2089

-

2096

.

58.

Viviano

BL

,

Paine-Saunders

S

,

Gasiunas

N

,

Gallagher

J

,

Saunders

S

.

Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin

.

J Biol Chem

.

2004

;

279

(

7

):

5604

-

5611

.

59.

Wang

Y

,

Liu

X

,

Obser

T

, et al.

Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis

.

Matrix Biol

.

2022

;

111

:

76

-

94

.

60.

Majka

M

,

Janowska-Wieczorek

A

,

Ratajczak

J

, et al.

Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner

.

Blood

.

2001

;

97

(

10

):

3075

-

3085

.

61.

Lortat-Jacob

H

,

Grosdidier

A

,

Imberty

A

.

Structural diversity of heparan sulfate binding domains in chemokines

.

Proc Natl Acad Sci U S A

.

2002

;

99

(

3

):

1229

-

1234

.

62.

Hook

M

,

Bjork

I

,

Hopwood

J

,

Lindahl

U

.

Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin

.

FEBS Lett

.

1976

;

66

(

1

):

90

-

93

.

63.

Lam

L

,

Silbert

J

,

Rosenberg

R

.

The separation of active and inactive forms of heparin

.

Biochem Biophys Res Commun

.

1976

;

69

(

2

):

570

-

577

.

64.

Lindahl

U

,

Bäckström

G

,

Thunberg

L

,

Leder

IG

.

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

.

Proc Natl Acad Sci U S A

.

1980

;

77

(

11

):

6551

-

6555

.

65.

Mazzon

C

,

Anselmo

A

,

Soldani

C

, et al.

Agrin is required for survival and function of monocytic cells

.

Blood

.

2012

;

119

(

23

):

5502

-

5511

.

66.

Anselmo

A

,

Lauranzano

E

,

Soldani

C

, et al.

Identification of a novel agrin-dependent pathway in cell signaling and adhesion within the erythroid niche

.

Cell Death Differ

.

2016

;

23

(

8

):

1322

-

1330

.

67.

Abrink

M

,

Grujic

M

,

Pejler

G

.

Serglycin is essential for maturation of mast cell secretory granule

.

J Biol Chem

.

2004

;

279

(

39

):

40897

-

40905

.

68.

Woulfe

DS

,

Lilliendahl

JK

,

August

S

, et al.

Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice

.

Blood

.

2008

;

111

(

7

):

3458

-

3467

.

69.

Grujic

M

,

Braga

T

,

Lukinius

A

, et al.

Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage

.

J Biol Chem

.

2005

;

280

(

39

):

33411

-

33418

.

70.

Wernersson

S

,

Braga

T

,

Sawesi

O

, et al.

Age-related enlargement of lymphoid tissue and altered leukocyte composition in serglycin-deficient mice

.

J Leukoc Biol

.

2009

;

85

(

3

):

401

-

408

.

71.

Khurana

S

,

Margamuljana

L

,

Joseph

C

,

Schouteden

S

,

Buckley

SM

,

Verfaillie

CM

.

Glypican-3–mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance

.

Blood

.

2013

;

121

(

14

):

2587

-

2595

.

72.

Viviano

BL

,

Silverstein

L

,

Pflederer

C

,

Paine-Saunders

S

,

Mills

K

,

Saunders

S

.

Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification

.

Dev Biol

.

2005

;

282

(

1

):

152

-

162

.

73.

Spinler

K

,

Bajaj

J

,

Ito

T

, et al.

A stem cell reporter-based platform to identify and target drug resistant stem cells in myeloid leukemia

.

Nat Commun

.

2020

;

11

:

5998

. 15.

https://doi.org/10.1101/2020.05.04.076786

74.

Lamichhane

BS

,

Bisgrove

BW

,

Su

Y-C

,

Demarest

BL

,

Yost

HJ

.

Syndecan 2 regulates hematopoietic lineages and infection resolution in zebrafish

.

bioRxiv

.

Preprint posted online 5 May 2020

.

75.

Endo

T

,

Ito

K

,

Morimoto

J

, et al.

Syndecan 4 regulation of the development of autoimmune arthritis in mice by modulating B cell migration and germinal center formation

.

Arthritis Rheumatol

.

2015

;

67

(

9

):

2512

-

2522

.

76.

Grigorian

M

,

Liu

T

,

Banerjee

U

,

Hartenstein

V

.

The proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph gland

.

Dev Biol

.

2013

;

384

(

2

):

301

-

312

.

77.

Raman

C

,

Sestero

CM

,

Orlandella

RM

, et al.

TGF-β receptor 3 (betaglycan) regulates Th1 differentiation and T dependent B cell responses

.

J Immunol

.

2016

;

196

(

suppl 1

):

189.12

.

78.

Shekels

LL

,

Buelt-Gebhardt

M

,

Gupta

P

.

Effect of systemic heparan sulfate haploinsufficiency on steady state hematopoiesis and engraftment of hematopoietic stem cells

.

Blood Cells Mol Dis

.

2015

;

55

(

1

):

3

-

9

.

79.

Garner

OB

,

Yamaguchi

Y

,

Esko

JD

,

Videm

V

.

Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate

.

Immunology

.

2008

;

125

(

3

):

420

-

429

.

80.

Volpi

S

,

Yamazaki

Y

,

Brauer

PM

, et al.

EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay PID links heparan sulfate to thymopoiesis

.

J Exp Med

.

2017

;

214

(

3

):

623

-

637

.

81.

Wang

L

,

Fuster

M

,

Sriramarao

P

,

Esko

JD

.

Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during inflammatory responses

.

Nat Immunol

.

2005

;

6

(

9

):

902

-

910

.

82.

Forsberg

E

,

Pejler

G

,

Ringvall

M

, et al.

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

.

Nature

.

1999

;

400

(

6746

):

773

-

776

.

83.

Pallerla

SR

,

Lawrence

R

,

Lewejohann

L

, et al.

Altered heparan sulfate structure in mice with deleted NDST3 gene function

.

J Biol Chem

.

2008

;

283

(

24

):

16885

-

16894

.

84.

Axelsson

J

,

Xu

D

,

Kang

BN

, et al.

Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice

.

Blood

.

2012

;

120

(

8

):

1742

-

1751

.

85.

Anower-E-Khuda

MF

,

Habuchi

H

,

Nagai

N

,

Habuchi

O

,

Yokochi

T

,

Kimata

K

.

Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin

.

J Biol Chem

.

2013

;

288

(

6

):

3705

-

3717

.

86.

Habuchi

H

,

Nagai

N

,

Sugaya

N

,

Atsumi

F

,

Stevens

RL

,

Kimata

K

.

Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality

.

J Biol Chem

.

2007

;

282

(

21

):

15578

-

15588

.

87.

Benhamron

S

,

Reiner

I

,

Zcharia

E

, et al.

Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice

.

PLoS One

.

2012

;

7

(

5

):

e35602

.

88.

Poon

I K

,

Goodall

KJ

,

Phipps

S

, et al.

Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation

.

Eur J Immunol

.

2014

;

44

(

4

):

1016

-

1030

.

89.

Jackson

DG

,

Bell

JI

,

Dickinson

R

,

Timans

J

,

Shields

J

,

Whittle

N

.

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

.

J Cell Biol

.

1995

;

128

(

4

):

673

-

685

.

90.

Forsberg

EC

,

Prohaska

SS

,

Katzman

S

,

Heffner

GC

,

Stuart

JM

,

Weissman

IL

.

Differential expression of novel potential regulators in hematopoietic stem cells

.

PLoS Genet

.

2005

;

1

(

3

):

e28

.

91.

Termini

CM

,

Pang

A

,

Li

M

,

Fang

T

,

Chang

VY

,

Chute

JP

.

Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity

.

Blood

.

2022

;

139

(

2

):

188

-

204

.

92.

Murphy

AJ

,

Akhtari

M

,

Tolani

S

, et al.

ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice

.

J Clin Invest

.

2011

;

121

(

10

):

4138

-

4149

.

93.

Minguell

JJ

,

Tavassoli

M

.

Proteoglycan synthesis by hematopoietic progenitor cells

.

Blood

.

1989

;

73

(

7

):

1821

-

1827

.

94.

Randrianarison-Huetz

V

,

Laurent

B

,

Bardet

V

,

Blobe

GC

,

Huetz

F

,

Duménil

D

.

Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage

.

Blood

.

2010

;

115

(

14

):

2784

-

2795

.

95.

Baldwin

RJ

,

ten Dam

GB

,

van Kuppevelt

TH

, et al.

A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation

.

Stem Cells

.

2008

;

26

(

12

):

3108

-

3118

.

96.

Holley

RJ

,

Pickford

CE

,

Rushton

G

, et al.

Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides

.

J Biol Chem

.

2011

;

286

(

8

):

6241

-

6252

.

97.

Gupta

P

,

Oegema

TR

,

Brazil

JJ

,

Dudek

AZ

,

Slungaard

A

,

Verfaillie

CM

.

Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins

.

Blood

.

2000

;

95

(

1

):

147

-

155

.

98.

Piszczatowski

RT

,

Schwenger

E

,

Sundaravel

S

, et al.

A glycan-based approach to cell characterization and isolation: hematopoiesis as a paradigm

.

J Exp Med

.

2022

;

219

(

11

):

e20212552

.

99.

Niemann

CU

,

Cowland

JB

,

Klausen

P

,

Askaa

J

,

Calafat

J

,

Borregaard

N

.

Localization of serglycin in human neutrophil granulocytes and their precursors

.

J Leukoc Biol

.

2004

;

76

(

2

):

406

-

415

.

100.

Niemann

CU

,

Abrink

M

,

Pejler

G

, et al.

Neutrophil elastase depends on serglycin proteoglycan for localization in granules

.

Blood

.

2007

;

109

(

10

):

4478

-

4486

.

101.

Glenthøj

A

,

Cowland

JB

,

Heegaard

NH

,

Larsen

MT

,

Borregaard

N

.

Serglycin participates in retention of α-defensin in granules during myelopoiesis

.

Blood

.

2011

;

118

(

16

):

4440

-

4448

.

102.

Dunzendorfer

S

,

Kaneider

N

,

Rabensteiner

A

, et al.

Cell-surface heparan sulfate proteoglycan–mediated regulation of human neutrophil migration by the serpin antithrombin III

.

Blood

.

2001

;

97

(

4

):

1079

-

1085

.

103.

Matzner

Y

,

Bar-Ner

M

,

Yahalom

J

,

Ishai-Michaeli

R

,

Fuks

Z

,

Vlodavsky

I

.

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. possible role in invasion through basement membranes

.

J Clin Invest

.

1985

;

76

(

4

):

1306

-

1313

.

104.

MOLLINEDO

F

,

Nakajima

M

,

Llorens

A

, et al.

Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils

.

Biochem J

.

1997

;

327

(

3

):

917

-

923

.

105.

Glerup

S

,

Kløverpris

S

,

Oxvig

C

.

The proform of the eosinophil major basic protein binds the cell surface through a site distinct from its C-type lectin ligand-binding region

.

J Biol Chem

.

2006

;

281

(

42

):

31509

-

31516

.

106.

Swaminathan

GJ

,

Myszka

DG

,

Katsamba

PS

,

Ohnuki

LE

,

Gleich

GJ

,

Acharya

KR

.

Eosinophil-granule major basic protein, a C-type lectin, binds heparin

.

Biochemistry

.

2005

;

44

(

43

):

14152

-

14158

.

107.

Temkin

V

,

Aingorn

H

,

Puxeddu

I

, et al.

Eosinophil major basic protein: first identified natural heparanase-inhibiting protein

.

J Allergy Clin Immunol

.

2004

;

113

(

4

):

703

-

709

.

108.

Jiang

A-P

,

Jiang

JF

,

Guo

MG

,

Jin

YM

,

Li

YY

,

Wang

JH

.

Human blood-circulating basophils capture HIV-1 and mediate viral trans-infection of CD4+ T cells

.

J Virol

.

2015

;

89

(

15

):

8050

-

8062

.

109.

Humphries

DE

,

Wong

GW

,

Friend

DS

, et al.

Heparin is essential for the storage of specific granule proteases in mast cells

.

Nature

.

1999

;

400

(

6746

):

769

-

772

.

110.

Bashkin

P

,

Razin

E

,

Eldor

A

,

Vlodavsky

I

.

Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix

.

Blood

.

1990

;

75

(

11

):

2204

-

2212

.

111.

Brule

S

,

Charnaux

N

,

Sutton

A

, et al.

The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9

.

Glycobiology

.

2006

;

16

(

6

):

488

-

501

.

112.

Slimani

H

,

Charnaux

N

,

Mbemba

E

, et al.

Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages

.

Biochim Biophys Acta

.

2003

;

1617

(

1-2

):

80

-

88

.

113.

Clasper

S

,

Vekemans

S

,

Fiore

M

, et al.

Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action

.

J Biol Chem

.

1999

;

274

(

34

):

24113

-

24123

.

114.

Zernichow

L

,

Åbrink

M

,

Hallgren

J

,

Grujic

M

,

Pejler

G

,

Kolset

SO

.

Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-α secretion in response to lipopolysaccharide

.

J Biol Chem

.

2006

;

281

(

37

):

26792

-

26801

.

115.

Martinez

P

,

Denys

A

,

Delos

M

, et al.

Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans

.

Glycobiology

.

2015

;

25

(

5

):

502

-

513

.

116.

Jones

M

,

Tussey

L

,

Athanasou

N

,

Jackson

DG

.

Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action

.

J Biol Chem

.

2000

;

275

(

11

):

7964

-

7974

.

117.

Gordts

PL

,

Foley

EM

,

Lawrence

R

, et al.

Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling

.

Cell Metab

.

2014

;

20

(

5

):

813

-

826

.

118.

Drzeniek

Z

,

Stöcker

G

,

Siebertz

B

, et al.

Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells

.

Blood

.

1999

;

93

(

9

):

2884

-

2897

.

119.

Gao

X

,

Lee

HY

,

da Rocha

EL

, et al.

TGF-β inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors

.

Blood

.

2016

;

128

(

23

):

2637

-

2641

.

120.

Kobayashi

K

,

Kato

K

,

Sugi

T

, et al.

Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface

.

J Biol Chem

.

2010

;

285

(

3

):

1716

-

1725

.

121.

Vogt

AM

,

Winter

G

,

Wahlgren

M

,

Spillmann

D

.

Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor

.

Biochem J

.

2004

;

381

(

Pt 3

):

593

-

597

.

122.

Schick

BP

,

Jacoby

JA

.

Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes

.

J Cell Physiol

.

1995

;

165

(

1

):

96

-

106

.

123.

Lord

MS

,

Cheng

B

,

Farrugia

BL

,

McCarthy

S

,

Whitelock

JM

.

Platelet factor 4 binds to vascular proteoglycans and controls both growth factor activities and platelet activation

.

J Biol Chem

.

2017

;

292

(

10

):

4054

-

4063

.

124.

Kaneider

NC

,

Feistritzer

C

,

Gritti

D

, et al.

Expression and function of syndecan-4 in human platelets

.

Thromb Haemost

.

2005

(

6

):

1120

-

1127

.

125.

Wan

LM

,

Zhang

SK

,

Li

SB

, et al.

Heparanase facilitates PMA-induced megakaryocytic differentiation in K562 cells via interleukin 6/STAT3 pathway

.

Thromb Haemost

.

2020

;

120

(

4

):

647

-

657

.

126.

Tan

Y-X

,

Cui

H

,

Wan

LM

, et al.

Overexpression of heparanase in mice promoted megakaryopoiesis

.

Glycobiology

.

2018

;

28

(

5

):

269

-

275

.

127.

Vögtle

T

,

Sharma

S

,

Mori

J

, et al.

Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

.

Elife

.

2019

;

8

:

e46840

.

128.

Falet

H

,

Rivadeneyra

L

,

Hoffmeister

KM

.

Clinical impact of glycans in platelet and megakaryocyte biology

.

Blood

.

2022

;

139

(

22

):

3255

-

3263

.

129.

Eustes

AS

,

Campbell

RA

,

Middleton

EA

, et al.

Heparanase expression and activity are increased in platelets during clinical sepsis

.

J Thromb Haemost

.

2021

;

19

(

5

):

1319

-

1330

.

130.

Sanderson

RD

,

Lalor

P

,

Bernfield

M

.

B lymphocytes express and lose syndecan at specific stages of differentiation

.

Cell Regul

.

1989

;

1

:

27

-

35

.

131.

van der Voort

R

,

Keehnen

RM

,

Beuling

EA

,

Spaargaren

M

,

Pals

ST

.

Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans

.

J Exp Med

.

2000

;

192

(

8

):

1115

-

1124

.

132.

Borghesi

LA

,

Yamashita

Y

,

Kincade

PW

.

Heparan sulfate proteoglycans mediate interleukin-7–dependent B lymphopoiesis

.

Blood

.

1999

;

93

(

1

):

140

-

148

.

133.

Reijmers

RM

,

Spaargaren

M

,

Pals

ST

.

Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma

.

FEBS J

.

2013

;

280

(

10

):

2180

-

2193

.

134.

Bret

C

,

Hose

D

,

Reme

T

, et al.

Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells

.

Br J Haematol

.

2009

;

145

(

3

):

350

-

368

.

135.

Jarousse

N

,

Trujillo

DL

,

Wilcox-Adelman

S

,

Coscoy

L

.

Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN

.

J Immunol

.

2011

;

187

(

11

):

5540

-

5547

.

136.

Aleman-Muench

GR

,

Mendoza

V

,

Stenvers

K

, et al.

Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis

.

PLoS One

.

2012

;

7

:

e44217

.

137.

Ortega-Francisco

S

,

de la Fuente-Granada

M

,

Alvarez Salazar

EK

, et al.

TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells

.

Biochem Biophys Res Commun

.

2017

;

494

(

1-2

):

82

-

87

.

138.

Khan

AA

,

Bose

C

,

Yam

LS

,

Soloski

MJ

,

Rupp

F

.

Physiological regulation of the immunological synapse by agrin

.

Science

.

2001

;

292

(

5522

):

1681

-

1686

.

139.

Zhang

J

,

Wang

Y

,

Chu

Y

, et al.

Agrin is involved in lymphocytes activation that is mediated by α-dystroglycan

.

FASEB J

.

2006

;

20

(

1

):

50

-

58

.

140.

Forster-Horváth

C

,

Bocsi

J

,

Rásó

E

, et al.

Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes

.

Eur J Immunol

.

2001

;

31

(

2

):

600

-

608

.

141.

Chung

J-S

,

Dougherty

I

,

Cruz

PD

,

Ariizumi

K

.

Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation

.

J Immunol

.

2007

;

179

(

9

):

5778

-

5784

.

142.

Sutton

VR

,

Brennan

AJ

,

Ellis

S

, et al.

Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity

.

FEBS J

.

2016

;

283

(

5

):

947

-

961

.

143.

Hsu

H-P

,

Chen

YT

,

Chen

YY

, et al.

Heparan sulfate is essential for thymus growth

.

J Biol Chem

.

2021

;

296

:

100419

.

144.

Wrenshall

LE

,

Platt

JL

.

Regulation of T cell homeostasis by heparan sulfate-bound IL-2

.

J Immunol

.

1999

;

163

(

7

):

3793

-

3800

.

145.

Wrenshall

LE

,

Platt

JL

,

Stevens

ET

,

Wight

TN

,

Miller

JD

.

Propagation and control of T cell responses by heparan sulfate-bound IL-2

.

J Immunol

.

2003

;

170

(

11

):

5470

-

5474

.

https://doi.org/10.1101/2023.02.26.529772

146.

Martinez

HA

,

Koliesnik

I

,

Kaber

G

, et al.

FOXP3⁺ regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues

.

bioRxiv

.

Preprint published online 27 February 2023

.

147.

Naparstek

Y

,

Cohen

IR

,

Fuks

Z

,

Vlodavsky

I

.

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase

.

Nature

.

1984

;

310

(

5974

):

241

-

244

.

148.

de Parseval

A

,

Bobardt

MD

,

Chatterji

A

, et al.

A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs

.

J Biol Chem

.

2005

;

280

(

47

):

39493

-

39504

.

149.

Clausen

TM

,

Sandoval

DR

,

Spliid

CB

, et al.

SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2

.

Cell

.

2020

;

183

(

4

):

1043

-

1057.e15

.

150.

Jones

KS

,

Petrow-Sadowski

C

,

Bertolette

DC

,

Huang

Y

,

Ruscetti

FW

.

Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells

.

J Virol

.

2005

;

79

(

20

):

12692

-

12702

.

151.

Rusnati

M

,

Coltrini

D

,

Oreste

P

, et al.

Interaction of HIV-1 Tat protein with heparin: role of the backbone structure, sulfation, and size

.

J Biol Chem

.

1997

;

272

(

17

):

11313

-

11320

.

152.

Shen

X-R

,

Geng

R

,

Li

Q

, et al.

ACE2-independent infection of T lymphocytes by SARS-CoV-2

.

Signal Transduct Target Ther

.

2022

;

7

:

83

.

153.

Hecht

M-L

,

Rosental

B

,

Horlacher

T

, et al.

Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences

.

J Proteome Res

.

2009

;

8

(

2

):

712

-

720

.

154.

Zilka

A

,

Landau

G

,

Hershkovitz

O

, et al.

Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46

.

Biochemistry

.

2005

;

44

:

14477

-

14485

.

155.

Brusilovsky

M

,

Radinsky

O

,

Cohen

L

, et al.

Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in-cis: a lesson from NKp44

.

Eur J Immunol

.

2015

;

45

(

4

):

1180

-

1191

.

156.

Elkin

M

.

Role of heparanase in macrophage activation

.

Adv Exp Med Biol

.

2020

;

1221

:

445

-

460

.

157.

Ishai-Michaeli

R

,

Eldor

A

,

Vlodavsky

I

.

Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix

.

Cell Regul

.

1990

;

1

(

11

):

833

-

842

.

158.

Matzner

Y

,

Vlodavsky

I

,

Bar-Ner

M

,

Ishai-Michaeli

R

,

Tauber

A I

.

Subcellular localization of heparanase in human neutrophils

.

J Leukoc Biol

.

1992

;

51

(

6

):

519

-

524

.

159.

Vlodavsky

I

,

Eldor

A

,

Haimovitz-Friedman

A

, et al.

Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation

.

Invasion Metastasis

.

1992

;

12

(

2

):

112

-

127

.

160.

Gutter-Kapon

L

,

Alishekevitz

D

,

Shaked

Y

, et al.

Heparanase is required for activation and function of macrophages

.

Proc Natl Acad Sci U S A

.

2016

;

113

(

48

):

E7808

-

E7817

.

161.

Putz

EM

,

Mayfosh

AJ

,

Kos

K

, et al.

NK cell heparanase controls tumor invasion and immune surveillance

.

J Clin Invest

.

2017

;

127

(

7

):

2777

-

2788

.

162.

Saez

B

,

Ferraro

F

,

Yusuf

RZ

, et al.

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

.

Blood

.

2014

;

124

(

19

):

2937

-

2947

.

163.

Dennissen

MA

,

Jenniskens

GJ

,

Pieffers

M

, et al.

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

.

J Biol Chem

.

2002

;

277

(

13

):

10982

-

10986

.

164.

van Kuppevelt

TH

,

Dennissen

MA

,

van Venrooij

WJ

,

Hoet

RM

,

Veerkamp

JH

.

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology: further evidence for heparan sulfate heterogeneity in the kidney

.

J Biol Chem

.

1998

;

273

(

21

):

12960

-

12966

.

165.

Attreed

M

,

Desbois

M

,

Van Kuppevelt

TH

,

Bülow

HE

.

Direct visualization of specifically modified extracellular glycans in living animals

.

Nat Methods

.

2012

;

9

(

5

):

477

-

479

.